[Construction, expression and bioactivity characterization of targeting toxin DT-VEGF]

Sheng Wu Gong Cheng Xue Bao. 2004 Mar;20(2):192-6.
[Article in Chinese]

Abstract

Tumor rapid growth depends on neovascularization. Vascular endothelial growth factor, the main mediator during the occurrence and formation of vascularization, has specific receptors whose expression rate shows difference of orders of magnitude between tumor and the normal tissue, so it can be used to transport toxin molecules to the proliferative tumor endothelial and kill cancer cells. In our experiment, we constructed fusion protein DT-VEGF by linking diphtheria toxin's forward 389 amino acids's gene and VEGF165 via a linker. DT-VEGF is expressed in E. coli and purified. Our experiment proves in can kill vascular endothelial cells specifically, and the inhibition of neovascularization of chicken chorionic membrane is also confirmed.

MeSH terms

  • Angiogenesis Inhibitors / biosynthesis
  • Diphtheria Toxin / biosynthesis
  • Diphtheria Toxin / genetics*
  • Escherichia coli / genetics
  • Escherichia coli / metabolism
  • Genetic Vectors
  • Humans
  • Immunotoxins / genetics*
  • Recombinant Fusion Proteins / biosynthesis*
  • Recombinant Fusion Proteins / genetics
  • Vascular Endothelial Growth Factors / biosynthesis*
  • Vascular Endothelial Growth Factors / genetics

Substances

  • Angiogenesis Inhibitors
  • Diphtheria Toxin
  • Immunotoxins
  • Recombinant Fusion Proteins
  • Vascular Endothelial Growth Factors